American Society of Hirudotherapy

Leech Therapy for Lateral Epicondylitis — RCT

Randomized controlled trial extending leech therapy evidence to tendinopathy

Last Updated: March 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Clinical TrialsMichalsen A et al. · Clinical Journal of Pain, 2014

Summary

Randomized controlled trial evaluating leech therapy versus topical diclofenac for chronic lateral epicondylitis (tennis elbow). Demonstrated significant pain reduction and improved grip strength in the leech therapy group, extending the clinical evidence for hirudotherapy beyond osteoarthritis to tendinopathies.

Why This Matters for Hirudotherapy

Broadens the evidence base for leech therapy to musculoskeletal conditions beyond OA. Suggests that the analgesic and anti-inflammatory mechanisms are generalizable across musculoskeletal pathologies, supporting a multi-indication clinical profile.

Citation

Effectiveness of Leech Therapy in Chronic Lateral Epicondylitis: A Randomized Controlled Trial

Michalsen A et al. · Clinical Journal of Pain, 2014

Added to ASH library: March 18, 2026 · Site last updated: March 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.

Leech Therapy for Lateral Epicondylitis — RCT | ASH